Generac Holdings, Inc. GNRC 深 滬
已收盤 12-12 16:00:00 美东时间
160.75
-6.900
-4.12%
華盛通- 最 高167.945
- 今 開167.49
- 成交量 91.12万股
- 最 低 158.1388
- 昨 收 167.65
- 總市值 94.33亿
- 52周最高 203.2499
- 市盈率 靜 29.83
- 換手率 1.55%
- 52周最低 99.50
- 委 比 55.04%
- 總股本 5868.41万
- 歷史最高 524.31
- 量 比 1.30
- 振 幅 5.85%
- 歷史最低 9.41
- 每 手 1
- 風險率 24.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Shares of electrical equipment companies are trading lower amid overall market weakness.
Shares of electrical equipment companies are trading lower amid overall market ...
12-13 04:54
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
JP Morgan Upgrades Generac Hldgs to Overweight, Maintains Price Target to $200
JP Morgan analyst Mark Strouse upgrades Generac Hldgs (NYSE:GNRC) from Neutral to Overweight and maintains the price target from $200 to $200.
12-08 21:27
Alphabet Rallies To Record Highs, Bitcoin Falters At $94,000: What's Moving Markets Monday?
Wall Street kicked off the new week on a flat note after the worst weekly slump for tech stocks since April, as investors remained cautious ahead of a flood of economic data following the end of the government shutdown and NVIDIA Corp. (NASD
11-18 01:40
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
Canaccord Genuity Maintains Buy on Generac Hldgs, Maintains $240 Price Target
Canaccord Genuity analyst George Gianarikas maintains Generac Hldgs (NYSE:GNRC) with a Buy and maintains $240 price target.
10-30 21:39
Generac tumbles after miss on earnings, revenue; guidance trimmed
Generac Holdings (GNRC) shares fell 7.4% in the first hour of trading Wednesday after the company reported third-quarter results that fell short of Wall Street’s expectations for both profit and sales...
10-29 21:57
Market-Moving News for October 29th
CMBM: 376% | Cambium Networks Announced Integration Of ONE Network With Starlink To Optimize LEO Satellite Connections GNRC: -17% | Generac shares are trading lower after the company reported
10-29 19:19
